Breaking News Instant updates and real-time market news.

VYGR

Voyager Therapeutics

$20.23

1.56 (8.36%)

07:13
01/23/18
01/23
07:13
01/23/18
07:13

Voyager Therapeutics announces FDA clearance of VY-AADC IND application

Voyager Therapeutics announced that the FDA has cleared the Investigational New Drug, or IND, application for VY-AADC, allowing the company to formally initiate clinical trial sites, screen and begin dosing patients for its pivotal Phase 2-3 program for advanced Parkinson's disease. As part of this IND, the chemistry, manufacturing, and controls section included data demonstrating comparability between VY-AADC produced under good manufacturing practice, or GMP, using Voyager's baculovirus/Sf9 manufacturing process and VY-AADC produced using a mammalian cell system consisting of triple-transfection of human embryonic kidney cells.

VYGR Voyager Therapeutics
$20.23

1.56 (8.36%)

10/31/17
WEDB
10/31/17
NO CHANGE
Target $31
WEDB
Outperform
Voyager Therapeutics price target lowered to $31 from $36 at Wedbush
Wedbush analyst David Nierengarten lowered his price target for Voyager (VYGR) to $31 from $36 following Sanofi's (SNY) decision to not opt-in ex-U.S. rights to VY-AADC, despite positive Phase 1 experience, which he views as an assessment of commercial opportunity for gene therapies outside U.S., rather than a reflection of VY-AADC's clinical profile. The analyst expects Voyager to carry VY-AADC to registration in ex-U.S. regions without a partner, although resources will likely be focused on opportunity in U.S. where a stronger reimbursement environment exists. Nierengarten continues to see Voyager shares as undervalued, and reiterates an Outperform rating on the stock.
11/15/17
ADAM
11/15/17
NO CHANGE
Target $26
ADAM
Buy
Voyager Therapeutics volatile but long-term thesis intact, says Canaccord
Canaccord analyst Sumant Kulkarni updated his model on Voyager Therapeutics following its recent stock offering. The analyst said patience is necessary while owning the volatile stock, but his long-term thesis remains intact. Kulkarni believes the pullback in the shares is a buying opportunity and he reiterated his Buy rating on Voyager Therapeutics while lowering his price target to $26 from $35.
11/28/17
PIPR
11/28/17
INITIATION
Target $28
PIPR
Overweight
Voyager Therapeutics assumed with an Overweight at Piper Jaffray
Piper Jaffray analyst Charles Duncan assumed coverage of Voyager Therapeutics with an Overweight rating and $28 price target. The analyst believes VY-AADC may prove to be the first disease-modifying treatment in advanced Parkinson's Disease.
12/19/17
BTIG
12/19/17
INITIATION
Target $32
BTIG
Buy
Voyager Therapeutics initiated with a Buy at BTIG
BTIG analyst Dane Leone started Voyager Therapeutics with a Buy rating and $32 price target.

TODAY'S FREE FLY STORIES

SENS

Senseonics

$4.93

0.07 (1.44%)

15:37
06/21/18
06/21
15:37
06/21/18
15:37
Hot Stocks
Senseonics up 5% after reopening following FDA approval news »

Senseonics shares are up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

WATT

Energous

$16.10

-0.61 (-3.65%)

15:35
06/21/18
06/21
15:35
06/21/18
15:35
Options
Energous put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SENS

Senseonics

$4.93

0.07 (1.44%)

15:35
06/21/18
06/21
15:35
06/21/18
15:35
Hot Stocks
Breaking Hot Stocks news story on Senseonics »

Senseonics trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

LDOS

Leidos

$57.77

-0.57 (-0.98%)

15:29
06/21/18
06/21
15:29
06/21/18
15:29
Recommendations
Leidos analyst commentary  »

Leidos may have…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

LDOS

Leidos

$57.75

-0.59 (-1.01%)

, HRS

Harris

$143.06

-2.18 (-1.50%)

15:25
06/21/18
06/21
15:25
06/21/18
15:25
Periodicals
TSA terminates contract with Peraton, Washington Business Journal says »

The Transportation…

LDOS

Leidos

$57.75

-0.59 (-1.01%)

HRS

Harris

$143.06

-2.18 (-1.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

FOSL

Fossil

$31.65

2.43 (8.32%)

15:25
06/21/18
06/21
15:25
06/21/18
15:25
Options
Fossil call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$274.42

-1.58 (-0.57%)

, SPX

S&P 500

$0.00

(0.00%)

15:22
06/21/18
06/21
15:22
06/21/18
15:22
Technical Analysis
Technical Take: S&P 500 at important technical juncture into the close »

Last week in a summary…

SPY

SPDR S&P 500 ETF Trust

$274.42

-1.58 (-0.57%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$54.58

0.08 (0.15%)

15:17
06/21/18
06/21
15:17
06/21/18
15:17
Periodicals
Wells Fargo said to let go of 10 analysts to cut costs, Bloomberg reports »

Wells Fargo is said to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jul

  • 12

    Apr

  • 16

    Jul

  • 15

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
06/21/18
06/21
15:17
06/21/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
06/21/18
06/21
15:16
06/21/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SENS

Senseonics

$4.93

0.07 (1.44%)

15:15
06/21/18
06/21
15:15
06/21/18
15:15
Hot Stocks
Senseonics says FDA approves PMA to market Eversense CGM System »

Senseonics Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

15:15
06/21/18
06/21
15:15
06/21/18
15:15
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

SRE

Sempra Energy

$111.85

-0.68 (-0.60%)

15:12
06/21/18
06/21
15:12
06/21/18
15:12
Hot Stocks
CPUC rejects SGE&E, SoCalGas request to build new nat gas pipeline in San Diego »

The California Public…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSX

CSX

$64.28

-0.59 (-0.91%)

15:10
06/21/18
06/21
15:10
06/21/18
15:10
Options
CSX sees increased put activity »

CSX sees increased put…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 26

    Aug

MFG

Mizuho Financial Group

$3.37

-0.07 (-2.03%)

15:05
06/21/18
06/21
15:05
06/21/18
15:05
Conference/Events
Mizuho Financial Group management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

HRTX

Heron Therapeutics

$40.10

9.4 (30.62%)

15:04
06/21/18
06/21
15:04
06/21/18
15:04
Recommendations
Heron Therapeutics analyst commentary  »

Heron Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

  • 26

    Jun

  • 27

    Jun

SGH

Smart Global

$40.24

-0.27 (-0.67%)

15:04
06/21/18
06/21
15:04
06/21/18
15:04
Options
SMART Global options imply 15.6% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

  • 07

    Jul

  • 09

    Jul

  • 10

    Jul

  • 12

    Jul

STMP

Stamps.com

$249.35

-30.95 (-11.04%)

15:02
06/21/18
06/21
15:02
06/21/18
15:02
Recommendations
Stamps.com analyst commentary  »

Any selloff in Stamps.com…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPSH

CPS Technologies

$1.57

(0.00%)

14:58
06/21/18
06/21
14:58
06/21/18
14:58
Hot Stocks
CPS Technologies names Francis J. Hughes, Jr. chairman of the board »

CPS Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRE

Sempra Energy

$113.35

0.82 (0.73%)

14:56
06/21/18
06/21
14:56
06/21/18
14:56
Periodicals
Sempra Energy to defend strategy, push back against activists, Dealreporter says »

Sempra Energy was caught…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SENS

Senseonics

$4.90

0.04 (0.82%)

14:55
06/21/18
06/21
14:55
06/21/18
14:55
Hot Stocks
Breaking Hot Stocks news story on Senseonics »

Senseonics trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

IR

Ingersoll-Rand

$90.32

-0.595 (-0.65%)

14:52
06/21/18
06/21
14:52
06/21/18
14:52
Conference/Events
Ingersoll-Rand management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

RHT

Red Hat

$166.01

-3.25 (-1.92%)

14:49
06/21/18
06/21
14:49
06/21/18
14:49
Options
Red Hat options imply 7.8% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

14:45
06/21/18
06/21
14:45
06/21/18
14:45
General news
June PMI reports from the U.S. and Europe are anxiously awaited Friday »

June PMI reports from the…

HES

Hess Corp.

$61.89

-0.75 (-1.20%)

14:44
06/21/18
06/21
14:44
06/21/18
14:44
Conference/Events
Hess Corp. management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.